Literature DB >> 16985641

Lymph node dissection in patients with kidney cancer: when is it indicated?

Ganesh S Palapattu, Hyung L Kim, Arie S Belldegrun.   

Abstract

It is necessary to consider the potential risks and benefits of performing a lymph node dissection (LND) at the time of radical nephrectomy. LND may lead to more accurate staging, a decrease in local recurrence, and an increase in survival for patients with metastatic disease limited to the resected lymph nodes. However, there are risks associated with the treatment that must be considered. The advantages of LND vary among patients, depending on the location and extent of disease progression. For patients with stage T3 or T4 disease, we recommend a limited LND. Patients with T3 or T4 disease with grossly positive nodes with or without hematogenous metastasis should undergo a more extensive LND.

Entities:  

Year:  2003        PMID: 16985641      PMCID: PMC1473016     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  12 in total

1.  Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.

Authors:  W Schafhauser; A Ebert; J Brod; S Petsch; K M Schrott
Journal:  Anticancer Res       Date:  1999 Mar-Apr       Impact factor: 2.480

2.  Improved prognostication of renal cell carcinoma using an integrated staging system.

Authors:  A Zisman; A J Pantuck; F Dorey; J W Said; O Shvarts; D Quintana; B J Gitlitz; J B deKernion; R A Figlin; A S Belldegrun
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

3.  Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.

Authors:  J H Blom; H van Poppel; J M Marechal; D Jacqmin; R Sylvester; F H Schröder; L de Prijck
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

4.  Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?

Authors:  A Minervini; L Lilas; G Morelli; C Traversi; S Battaglia; R Cristofani; R Minervini
Journal:  BJU Int       Date:  2001-08       Impact factor: 5.588

5.  The number of lymph nodes examined and staging accuracy in renal cell carcinoma.

Authors:  C Terrone; S Guercio; S De Luca; M Poggio; E Castelli; C Scoffone; R Tarabuzzi; R M Scarpa; D Fontana; S Rocca Rossetti
Journal:  BJU Int       Date:  2003-01       Impact factor: 5.588

6.  The role of lymphadenectomy in the management of renal cell carcinoma.

Authors:  P C Peters; G L Brown
Journal:  Urol Clin North Am       Date:  1980-10       Impact factor: 2.241

7.  Lymphadenectomy in renal adenocarcinoma.

Authors:  J P Siminovitch; J E Montie; R A Straffon
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

8.  Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.

Authors:  Allan J Pantuck; Amnon Zisman; Fredrick Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara J Gitlitz; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

9.  What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma.

Authors:  A Herrlinger; K M Schrott; G Schott; A Sigel
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

10.  Role of lymphadenectomy in the treatment of renal cell carcinoma.

Authors:  E Phillips; E M Messing
Journal:  Urology       Date:  1993-01       Impact factor: 2.649

View more
  1 in total

Review 1.  Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.

Authors:  Brian M Shinder; Kevin Rhee; Douglas Farrell; Nicholas J Farber; Mark N Stein; Thomas L Jang; Eric A Singer
Journal:  Front Oncol       Date:  2017-05-31       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.